Biotherapy & Oncology

The Graduate Program Biotherapy & Oncology federates and coordinates the Master's degrees, doctoral schools and research teams at the University of Paris-Saclay in the field of Cancer biology, Oncology and Biotherapies. In particular, it develops the entire field of investigation of Cancer Biology, from the understanding of the fundamental mechanisms at the origin of cancers (e.g. heredity, environment, aging, infection) to the implementation of adapted, innovative, personalized therapeutic approaches and the characterization of the impact of these treatments in the medium and long term. The Graduate Program Oncology & Biotherapy also raises the issue of biotherapies more broadly by developing gene, cell and tissue therapies against cancer or other diseases of genetic origin (e.g. monogenic diseases such as myopathies, immunodeficiency, haematopathologies) and/or age-related (e.g. neurodegenerative diseases)

Keywords (alphabetical order) : 3R (Replication, Repair, Recombination); Aging; Apoptosis; Autophagy; Bioinformatics; Biomaterials; Biomarkers; Cancer; Carcinomas; Cell cycle restriction points; Cell death; Chemotherapies; Chromosomal instability; Clinical trials; Cytotherapies; Diagnosis; Differentiation; Epigenetics; Etiology; Fibrosis; Genetic diseases; Genotherapeutics; Homing; Immunotherapy; Infection; Inflammation; Innovative pharmacotherapies; Invasion; Leukemia; Medulloblastoma; Melanomas; Metabolism; Metastasis; Microbiota; Modelling; Monogenic diseases; Mutagenesis; Myopathies; Nanotechnology; Necrosis; Oncology; Oncogenes; Oncogenic agents; Oncology; Pluripotent stem cells; Prognosis; Radiobiology; Radiation-induced tumours; Sequencing; Signalling; Signature; Stress; Theranostics; Therapies; Therapies; Translation; Tumors; Tumor progression; Tumor reversion; Tumor suppressors; Vectors; Surgical innovations; Therapeutic targets; Tumor environment; Tumor stem cells, Vectoring

Master programs

The Graduate Program Biotherapy & Oncology offers 5 Master courses :

• « Cancerology » (Cancero), from the biology of cancer to oncology, from the fundamental to the clinical;
• « Gene, Cell, Development » (GCD), from the biology of the cell to its normal or pathological development in the context of cancer;
• « Aging biology » (BiV), exploring in particular the link between ageing and cancer;
• « Immunology » (Immuno), exploring in particular the link between immunity and immunotherapies for cancer;
• « Biotherapies: Tissue, Cell & Gene » (BTCG) which specialises in innovative biotherapies, covering genotherapies (gene transfer, gene interventions), replacement cytotherapies (stem or differentiated cell manipulations), immunotherapy, innovative drug therapies, the use of biomaterials, high-throughput screening analyses and clinical research in biotherapy.

These training courses are open to scientific students, doctors, pharmacists, veterinarians and/or engineers, depending on the course.